VenoStent

About:

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Website: http://www.venostent.com

Twitter/X: venostent

Top Investors: Alumni Ventures, National Science Foundation, Y Combinator, Norwest Venture Partners, National Institutes of Health

Description:

VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. The company's technology is made from a new class of shape-memory polymers that are primarily used as an external stent in coronary artery bypass surgery and do not require sutures, allowing doctors to reduce surgery time, infection risk, and wound resuming in hemodialysis patients while also reducing failure from vein occlusion.

Total Funding Amount:

$29.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2017-01-01

Founders:

Geoffrey Lucks, Tim Boire

Number of Employees:

11-50

Last Funding Date:

2024-06-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai